DILANTIN

This brand name is authorized in Australia, Canada, France, Hong Kong, Israel, New Zealand, Singapore, United States

Active ingredients

The drug DILANTIN contains one active pharmaceutical ingredient (API):

1 Phenytoin UNII 6158TKW0C5 - PHENYTOIN

Phenytoin is effective in various animal models of generalised convulsive disorders, reasonably effective in models of partial seizures but relatively ineffective in models of myoclonic seizures. It appears to stabilise rather than raise the seizure threshold and prevents spread of seizure activity rather than abolish the primary focus of seizure discharge. Read about Phenytoin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DILANTIN Extended-release capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR
DILANTIN-125 Oral suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR
DILANTIN INFATABS Chewable tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AB02	Phenytoin	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AB Hydantoin derivatives
Discover more medicines within N03AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1249R, 1873N, 1874P, 2692Q
Country: CA	Health Products and Food Branch	Identifier(s): 00022772, 00022780, 00023442, 00023450, 00023698
Country: FR	Base de données publique des médicaments	Identifier(s): 62436200
Country: HK	Department of Health Drug Office	Identifier(s): 07909, 07913, 19932, 65291
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 433
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 743, 744, 747, 748
Country: SG	Health Sciences Authority	Identifier(s): 06056P, 09208P, 13114P
Country: US	FDA, National Drug Code	Identifier(s): 0071-0007, 0071-0369, 0071-2214, 0071-3740, 50090-0029, 70518-0980